Good morning, and welcome to Electromed's 2026 Annual Meeting of Shareholders. Most shareholders have already voted by proxy, and the proxies have been tallied. If you are a shareholder of record or a beneficial owner in possession of a legal proxy from your bank, broker, or nominee, and you want to vote your shares now or change your vote, you may do so during the meeting by clicking on the second icon from the top in the panel on the right side of the screen. Shareholders may also submit questions electronically during the meeting by clicking the first icon at the top of the panel on the right side of the screen and typing their question. Your question will not be visible to other attendees.
Representatives of the company will have an opportunity to respond to questions received during the meeting at the conclusion of all the prepared remarks to the extent time permits. I would now like to introduce Kathleen Skarvan, chair of the company's board of directors. Please go ahead.
Good morning, ladies and gentlemen. Welcome to the Annual Meeting of Shareholders. It is now 8:01 A.M. Central Standard Time, and the meeting is called to order, and the polls are open. I will serve as chair of the meeting. Joining us virtually are Jim Cunniff, our president and chief executive officer and a member of our board, and Brad Nagel, our chief financial officer, who also will serve as secretary of this meeting. In addition to myself and Mr. Cunniff, also joining us virtually today from our current board of directors and nominees are Stan Erickson, Greg Fluet, Joe Galatowitsch, Kathy Tune, and Andrea Walsh. Also present electronically is a representative of RSM, the company's independent registered public accounting firm, and Tony Carideo, who has been appointed to act as inspector for the meeting. Brad will now present to you the details of today's meeting.
Good morning. The record date for the determination of the holders of the company's common stock entitled to receive notice and to vote at this meeting was fixed by the board of directors to be September 16, 2026. An affidavit of mailing has been received from Broadridge attesting that a notice of internet availability or a full set of proxy materials was distributed to each holder of the company's common stock as of the close of business on the record date. The affidavit will be attached to the minutes of this meeting. As of close of business on the record date, there were 8,287,085 shares of common stock issued and outstanding, and each share is entitled to one vote.
The inspector of election has informed us that on a preliminary count, there are represented at this meeting, either in person or by proxy, holders of at least a majority of the outstanding shares of common stock, constituting a majority of the votes entitled to be cast at this meeting. Therefore, a quorum is present for the transaction of business, and the meeting can proceed.
Thank you, Brad. Please note that the polls will be closed shortly. We will now take up the business of the meeting, which consists of four proposals. First, election of the directors named in the proxy statement, thereby setting the number of directors at seven. Second, ratification of the appointment of RSM as the company's independent registered public accounting firm for the fiscal year ending June 30th, 2027. Third, approval on a non-binding and advisory basis of the executive compensation disclosed in the company's proxy statement for this meeting. Fourth, approval of Electromed Incorporated's employee stock purchase plan. The polls are now closed, and a final report of election will be prepared.
Thank you, Kathleen. The preliminary report of the inspector of election indicates that each of the seven director nominees received the affirmative vote of a plurality of the outstanding shares present at this meeting and entitled to vote. Accordingly, each has been elected to serve until the next Annual Meeting of Shareholders or until a successor is duly elected. Additionally, the size of the seven-member board is confirmed. The proposals to ratify the appointment of RSM US LLP, to approve our executive compensation on a non-advisory basis, and to approve the employee stock purchase plan each received the affirmative vote of a majority of the outstanding shares of common stock present at the meeting and entitled to vote, and therefore, each is also approved. The company plans to report the final voting results on a current report on Form 8-K.
There being no further business before this meeting, I declare the business portion of this meeting adjourned.
At this time, Electromed President and Chief Executive Officer, Jim Cunniff, will respond to questions received during the meeting. There being no questions, I will now turn over the call to Jim for closing remarks.
Thank you for your participation today and for your continued confidence in Electromed. We remain committed to advancing respiratory health, creating shareholder value, and transforming lives one breath at a time. Electromed delivered record financial performance in fiscal year 2026, and we are well-positioned to deliver another strong year in fiscal 2027. Thank you again for your time today.